The results of the investigation are inconclusive since the device was not returned for analysis.The device history record was not reviewed as the batch number was not available.Based on the information received, the cause of the reported cardiac tamponade, hematomas, and bradycardia could not be conclusively determined.
|
Related manufacturer reference: 3005334138-2019-00412, 2030404-2019-00065, 2030404-2019-00066.The following was published in jafib: journal of atrial fibrillation in an article titled "atrial fibrillation in heart failure patients with preserved or reduced ejection fraction - prognostic significance of rhythm control strategy with catheter ablation" by vecchio n, ripa l, orosco a, et al., february - march 2019.Vol 11 issue 5."atrial fibrillation (af) and heart failure (hf) often coexist with an increase in morbidity and mortality.Af catheter ablation (ca) has proved to be a safe and efficient option for hf patients, but long-term evolution and prognosis remain uncertain.The aim is to assess the efficacy and safety of ca in hf patients with af, and analyze hf long-term evolution.Consecutive patients with af and congestive hf or left ventricular ejection fraction (ef) less than 45%, who underwent ca of af between 2011 and 2016, were prospectively analyzed.It was concluded that catheter ablation of atrial fibrillation in heart failure presents an adequate success rate, improving symptoms and reducing rehospitalizations due to heart failure.However, during the study two cardiac tamponades requiring pericardiocentesis, three groin hematomas and 1 case of extreme bradycardia were observed.".
|